Oncolocy Venture Sweden AB will be transferred to AktieTorget:s observation list

Oncology Venture Sweden AB published today March 9, 2018 a press release with information regarding a proposed merger of Oncology Venture Sweden AB and Medical Prognosis Institute.

AktieTorget has decided that the shares in Oncology Venture Sweden AB will be traded on AktieTorgets observation list from today March 9, 2018.

AktieTorget
08-511 68 000
e-post informationsoverakningen@aktietorget.se 

About AktieTorget

AktieTorget is a market place that wants to make it easier, safer and more visible for growth companies to become- and be listed. The company also offers investors the opportunity to become shareholders in growth companies in an easier and safer way. At AktieTorget there are more than 160 listed growth companies from different industries. AktieTorget was founded 1997, have 20 employees and head office in Stockholm. Read more at www.aktietorget.se